Moreover, we also demonstrated that the chronic infusion of amyloid-β peptide led to an increase in the density of B1R and B2R in brain regions associated with cognitive processes, as well as an increase in BK concentration in cerebrospinal fluid, suggesting the involvement of KKS activation in AD [6,15]. This evidence concerns the gene BDKRB2 and Alzheimer disease.